Screening for Colorectal Neoplasias with Fecal Occult Blood Tests: False-positive Impact of Non-Dietary Restriction

被引:9
|
作者
Roslani, April Camilla [1 ]
Abdullah, Taufiq [2 ]
Arumugam, Kulenthran [1 ]
机构
[1] Univ Malaya, Canc Res Inst, Kuala Lumpur, Malaysia
[2] Univ Malaya, Med Educ & Res Dev Unit, Kuala Lumpur, Malaysia
关键词
Colorectal cancer; fecal occult blood test; screening; diet restriction; CANCER STATISTICS; CONTROLLED TRIAL; COLONOSCOPY; POPULATION; SURVIVAL;
D O I
10.7314/APJCP.2012.13.1.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Screening for colorectal cancer using guaiac-based fecal occult blood tests (gFOBT) is well established in Western populations, but is hampered by poor patient compliance due to the imposed dietary restrictions. Fecal immunochemical tests (FIT) do not require dietary restriction, but are more expensive than gFOBT and therefore restrict its use in developing countries in Asia. However, Asian diets being low in meat content may not require diet restriction for gFOBT to achieve equivalent results. The objective of this study was to evaluate and compare the validity and suitability of gFOBT and FIT or a combination of the two in screening for colorectal neoplasias without prior dietary restriction in an Asian population. Methods: Patients referred to the Endoscopic Unit for colonoscopy were recruited for the study. Stool samples were collected prior to bowel preparation, and tested for occult blood with both gFOBT and FIT. Dietary restriction was not imposed. To assess the validity of either tests or in combination to detect a neoplasm or cancer in the colon, their false positive rates, their sensitivity (true positive rate) and the specificity (true negative rate) were analyzed and compared. Results: One hundred and three patients were analysed. The sensitivity for picking up any neoplasia was 53% for FIT, 40% for gFOBT and 23.3% for the combination. The sensitivities for picking up only carcinoma were 77.8%, 66.7% and 55.5%, respectively. The specificity for excluding any neoplasia was 91.7% for FIT, 74% for gFOBT and 94.5% for a combination, whereas for excluding only carcinomas they were 84%, 73.4% and 93.6%. Of the 69 with normal colonoscopic findings, FOBT was positive in 4.3%, 23.2 % and 2.9% for FIT, gFOBT, or combination of tests respectively. Conclusion: FIT is the recommended method if we are to dispense with dietary restriction in our patients because of its relatively low-false positivity and better sensitivity and specificity rates.
引用
收藏
页码:237 / 241
页数:5
相关论文
共 50 条
  • [41] Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population
    van Rossum, Leo G.
    van Rijn, Anne F.
    Laheij, Robert J.
    van Oijen, Martijn G.
    Fockens, Paul
    van Krieken, Han H.
    Verbeek, Andre L.
    Jansen, Jan B.
    Dekker, Evelien
    GASTROENTEROLOGY, 2008, 135 (01) : 82 - 90
  • [42] IMPACT OF MODIFICATIONS IN FECAL OCCULT BLOOD TEST ON SCREENING-PROGRAM FOR COLORECTAL NEOPLASIA
    WINAWER, S
    GINTHER, M
    WESTON, E
    REICHLIN, B
    FLEISHER, M
    CIRONE, C
    SCHOTTENFELD, D
    MILLER, D
    GASTROENTEROLOGY, 1978, 74 (05) : 1151 - 1151
  • [43] Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing
    Helm, JF
    Russo, MW
    Biddle, AK
    Simpson, KN
    Ransohoff, DF
    Sandler, RS
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (11): : 3250 - 3258
  • [44] Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis
    de Klerk, Clasine M.
    Vendrig, Lisanne M.
    Bossuyt, Patrick M.
    Dekker, Evelien
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (12): : 1778 - 1787
  • [45] Aspirin Users Attending for NHS Bowel Cancer Screening Have Less Colorectal Neoplasia: Chemoprevention or False-Positive Faecal Occult Blood Testing?
    Lee, Thomas J. W.
    Hull, Mark A.
    Rajasekhar, Praveen T.
    Clifford, Gayle M.
    Ritchie, Mary
    James, Peter
    McNally, Richard J. Q.
    Rutter, Matthew D.
    Rees, Colin J.
    DIGESTION, 2012, 85 (04) : 278 - 281
  • [46] The impact of a false-positive colorectal cancer-screening test on quality of life: a systematic review
    van der Velde, Jantina L.
    Blanker, Marco H.
    Berger, Marjolein Y.
    Berendsen, Annette J.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 33 - 33
  • [47] FECAL OCCULT BLOOD SCREENING FOR COLORECTAL NEOPLASIA - A RANDOMIZED TRIAL OF 3 DAYS OR 6 DAYS OF TESTS
    THOMAS, WM
    PYE, G
    HARDCASTLE, JD
    MANGHAM, CM
    BRITISH JOURNAL OF SURGERY, 1990, 77 (03) : 277 - 279
  • [48] REPEAT FECAL OCCULT BLOOD TESTS FOR COLORECTAL CANCER SCREENING: SYSTEMATIC REVIEW AND META-ANALYSIS
    Murphy, Caitlin C.
    Sen, Ahana
    Sigel, Bianca
    Mayo, Helen
    Singal, Amit G.
    GASTROENTEROLOGY, 2019, 156 (06) : S813 - S813
  • [49] Inappropriate and improper use of fecal occult blood tests for colorectal cancer screening in the VA Medical System
    Ahmed, F
    Murthy, UK
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (06): : 1401 - 1401
  • [50] Comparison of fecal occult blood tests for screening of colorectal neoplasia: A prospective study with total colonoscopy.
    Han, DS
    Park, JY
    Lee, OY
    Sohn, JH
    Yoon, BC
    Choi, HS
    Hahm, JS
    Lee, MH
    Khee, CS
    Park, KN
    Park, IK
    GASTROENTEROLOGY, 1997, 112 (04) : A574 - A574